Review of Cutaneous Melanoma Quality Performance Indicators Consultation

Overview

Under the auspices of the Scottish Cancer Taskforce, National Cancer Quality Performance Indicators (QPIs) were developed to drive continuous quality improvement in cancer care across NHSScotland.  In June 2014, Cutaneous Melanoma QPIs were published, and following 3 years of national comparative data, these have now been subject to formal review.  In order to ensure success of the National Cancer QPIs in driving quality improvement it is critical that QPIs continue to be clinically relevant and focus on areas which will result in improvements to the quality of patient care. 

Why your views matter

Wide clinical and public engagement is crucial to ensure wide inclusiveness of clinical colleagues across NHSScotland. It is also vital to include the patients and the public as key stakeholders in this consultation to ensure the acceptability of the QPIs. We would like your comments on the Cutaneous Melanoma QPIs. In particular we would like to hear your views on:

• The appropriateness of the QPIs that have been developed.
• The target levels that have been set.
• Key points or areas that are not covered within the QPIs 
• Feasibility of measuring the QPIs identified in a meaningful and comparative way (i.e. ‘like for like’ comparison)

Forms to assist with submission of comments have been developed and should be used wherever possible. Please note that supporting evidence should be detailed along with comments where appropriate.

Download the Cutaneous Melanoma Clinical Quality Performance Indicators Engagement Document.

What happens next

All responses will be collated for review and decision by the Cutaneous Melanoma QPI Review Group. Those who have participated in the engagement process will receive an overview of the changes made and a copy of the final Cutaneous Melanoma QPI document, ahead of publication in 2018.